Skip to main content

Table 4 Comparison of area under curve (AUC) of various parameters for prediction of composite end-point (ROC analysis)

From: Multimodal assessment of right ventricle overload-metabolic and clinical consequences in pulmonary arterial hypertension

Value

AUC (95% confidence interval)

p-value

RV GLS/PASP

0.96 (0.88–1)

p < 0.001

RV GLS/PVR

0.94 (0.86–1)

p < 0.001

RV GLS*PAC

0.89 (0.76–1)

p < 0.001

RV GLS

0.87 (0.73–1)

p < 0.001

SUVRV/LV

0.84 (0.67–1)

p < 0.001

RVEF

0.83 (0.65–1)

p < 0.001

PVR

0.88 (0.75–1)

p = 0.04

PAC

0.72 (0.52–0.92)

p = 0.03

TAPSE/RVSP (echo/echo)

0.79 (0.62–0.96)

p = 0.005

TAPSE/RVSP (CMR/echo)

0.76 (0.58–0.94)

p = 0.004

RV GLS/RVSP (CMR/echo)

0.89 (0.77–1)

p < 0.001

RVEF/RVSP (CMR/echo)

0.78 (0.58–0.96)

p = 0.002

  1. CMR cardiac magnetic resonance, echo echocardiography, GLS global longitudinal strain, LV left ventricle, PAC pulmonary arterial compliance, PASP pulmonary artery systolic pressure, PET positron emission tomography, PVR pulmonary vascular resistance, RV right ventricle, RVEF right ventricle ejection fraction, RVSP right ventricle systolic pressure obtained by echocardiography, SUV standardized uptake value, TAPSE tricuspid annular plane systolic excursion